Editorial: Risk Factors and Outcome Predicating Biomarker of Neurodegenerative Diseases

Editorial: Risk Factors and Outcome Predicating Biomarker of Neurodegenerative Diseases

Bibliographic Details
Main Authors:	Chaur-Jong Hu, Jean-Noël Octave
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2019-02-01
Series:	Frontiers in Neurology
Subjects:	neurodegeneration Alzheimer's disease Parkinson's disease predication biomarker
Online Access:	https://www.frontiersin.org/article/10.3389/fneur.2019.00045/full

Similar Items

Endothelial Dysfunction in Neurodegenerative Diseases
by: Yao-Ching Fang, et al.
Published: (2023-02-01)

Editorial: Body fluid biomarkers in neurodegenerative studies: Novel insights into pathophysiology to support clinical practice and drug development
by: Anastasia Bougea, et al.
Published: (2023-01-01)

Phenotype-Agnostic Molecular Subtyping of Neurodegenerative Disorders: The Cincinnati Cohort Biomarker Program (CCBP)
by: Andrea Sturchio, et al.
Published: (2020-10-01)

Clinical trials of new drugs for Alzheimer disease
by: Li-Kai Huang, et al.
Published: (2020-01-01)

Current and future trends in biomarkers for the early detection of Alzheimer's disease in Asia: expert opinion
by: Kandiah, Nagaendran, et al.
Published: (2024)

Molecular diagnostics of neurodegenerative disorders
by: Megha eAgrawal, et al.
Published: (2015-09-01)

Risk Factors for Postischemic Stroke Epilepsy in Young Adults: A Nationwide Population-Based Study in Taiwan
by: Phuong Thao Do, et al.
Published: (2022-05-01)

Editorial: Common Pathways Linking Neurodegenerative Diseases—The Role of Inflammation
by: Małgorzata Kujawska, et al.
Published: (2021-09-01)

Clinical trials of new drugs for Alzheimer disease: a 2020–2023 update
by: Li-Kai Huang, et al.
Published: (2023-10-01)

Frequency power and coherence of electroencephalography are correlated with the severity of Alzheimer's disease: A multicenter analysis in Taiwan
by: Chih-Chung Chen, et al.
Published: (2015-08-01)

Metabolomic Footprint of Disrupted Energetics and Amino Acid Metabolism in Neurodegenerative Diseases: Perspectives for Early Diagnosis and Monitoring of Therapy
by: Patrycja Maszka, et al.
Published: (2023-03-01)

Verbal predicate in the nominal predicate
by: Mirko Peti
Published: (2004-01-01)

Plasma Biomarkers Ascertained With Immunomagnetic Reduction Diagnosing Early-Stage Alzheimer's Disease: A Systematic Review
by: Pui-Un Tang, et al.
Published: (2021-01-01)

Amyloid-β peptide alteration of tau exon-10 splicing via the GSK3β-SC35 pathway
by: Kun-Lin Chen, et al.
Published: (2010-11-01)

Leveraging Plasma Membrane Repair Therapeutics for Treating Neurodegenerative Diseases
by: Hannah R. Bulgart, et al.
Published: (2023-06-01)

Antioxidant and Anti-Inflammatory Effects of <i>Citrus</i> Flavonoid Hesperetin: Special Focus on Neurological Disorders
by: Amjad Khan, et al.
Published: (2020-07-01)

Chronic sleep disturbance and neural injury: links to neurodegenerative disease
by: Abbott SM, et al.
Published: (2016-01-01)

Copper Dyshomeostasis in Neurodegenerative Diseases—Therapeutic Implications
by: Grażyna Gromadzka, et al.
Published: (2020-12-01)

TLR-Mediated Signal Transduction and Neurodegenerative Disorders
by: Shashank Vishwanath Adhikarla, et al.
Published: (2021-10-01)

The Cell and Molecular Biology of Neurodegenerative diseases: An Overview
by: Heather Lynn Montie, et al.
Published: (2013-11-01)

Natural Products as the Potential to Improve Alzheimer’s and Parkinson’s Disease
by: Sung Wook Kim, et al.
Published: (2023-05-01)

Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases
by: Julia Doroszkiewicz, et al.
Published: (2022-04-01)

Telehealth in Neurodegenerative Diseases: Opportunities and Challenges for Patients and Physicians
by: Fabiola De Marchi, et al.
Published: (2021-02-01)

Search for Molecular Biomarkers of Parkinson’s Disease. New Tissues and Methods
by: Peter Racay
Published: (2023-04-01)

Beware of Misdelivery: Multifaceted Role of Retromer Transport in Neurodegenerative Diseases
by: Shun Yoshida, et al.
Published: (2022-05-01)

Evaluation of Alpha-Synuclein Cerebrospinal Fluid Levels in Several Neurological Disorders
by: Luisa Agnello, et al.
Published: (2022-05-01)

Biomarkers of Neurodegenerative Diseases: Biology, Taxonomy, Clinical Relevance, and Current Research Status
by: Dorota Koníčková, et al.
Published: (2022-07-01)

Exploring the Potential of Aptamers in Targeting Neuroinflammation and Neurodegenerative Disorders: Opportunities and Challenges
by: Anna Hau-Yee Kong, et al.
Published: (2023-07-01)

Exploring neurodegenerative disorders using advanced magnetic resonance imaging of the glymphatic system
by: Jannik Prasuhn, et al.
Published: (2024-04-01)

Editorial: Proteomics as a Tool for Biomarker and Drug Target Discovery: Improving the Diagnosis and Treatment of Neurodegenerative Diseases
by: Olivia Belbin, et al.
Published: (2020-11-01)

Defective PTEN-induced kinase 1/Parkin mediated mitophagy and neurodegenerative diseases
by: Megan M. Braun, et al.
Published: (2022-10-01)

Editorial: Novel mechanisms involved in aging and neurodegeneration: Seeking potential therapeutic targets for neurodegenerative diseases
by: Mario Sanhueza, et al.
Published: (2022-12-01)

Editorial: Cholesterol and Neurodegenerative Diseases - Pressing Questions and How to Address Them
by: Sandrine Betuing, et al.
Published: (2022-06-01)

Relevance of Autophagy and Mitophagy Dynamics and Markers in Neurodegenerative Diseases
by: Carlotta Giorgi, et al.
Published: (2021-02-01)

Physical activity and lifestyle modifications in the treatment of neurodegenerative diseases
by: Jose A. Santiago, et al.
Published: (2023-05-01)

Pathological Circulating Factors in Moyamoya Disease
by: Yao-Ching Fang, et al.
Published: (2021-02-01)

Circulating miRNAs as Biomarkers for Neurodegenerative Disorders
by: Margherita Grasso, et al.
Published: (2014-05-01)

Plasma Phosphorylated-tau181 Is a Predictor of Post-stroke Cognitive Impairment: A Longitudinal Study
by: Li-Kai Huang, et al.
Published: (2022-04-01)

Proteomic Discovery and Validation of Novel Fluid Biomarkers for Improved Patient Selection and Prediction of Clinical Outcomes in Alzheimer’s Disease Patient Cohorts
by: Shivangi Awasthi, et al.
Published: (2022-08-01)

Pyrimidine analogues for the management of neurodegenerative diseases
by: Swati Pant, et al.
Published: (2022-12-01)